MedPath

Development and Evaluation of a Web-based Diet Quality Screener for Vegans - BELGIUM

Active, not recruiting
Conditions
Healthy
Registration Number
NCT06861205
Lead Sponsor
University Ghent
Brief Summary

The primary objective of this study is to assess the construct validity and criterion validity for associations of the VEGANScreener with nutrient intakes from reference methods and associations with biomarkers of dietary intake. The investigators hypothesize that the screener is a valid tool to assess diet quality in the vegan population. The study will assess construct validity by testing whether the measure relates as it should to other measures (e.g., age, gender, education, socioeconomic status differences).

The investigators will assess concurrent and predictive validity (types of criterion validity) by evaluating associations and agreement between 'gold standards', such as diet records, biomarkers, and multi-metabolite signatures of intake. The investigators will examine associations of vegan diet quality with biomarkers of nutritional status, biomarkers of disease, and anthropometric measures and hypothesize that a higher diet quality in vegans is associated with a more favourable profile among vegans, for example, a lower blood pressure. This study is part of the European VEGANScreener Consortium.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Self-reported vegans (≥2 years on a vegan diet; vegan diet defined as not consuming any dietary animal products more often than once/month, honey excluded)
  2. Self-reported omnivores. Consuming on average daily (at least 5 times/week) meat/meat products.
  3. Age 18 to 65 years (1:1 ratio 18-35,99 and 36-65)
  4. Males and females (1:1 ratio)
Exclusion Criteria
  1. Self-identified pescatarians (excluding all meat, except for fish/seafood) and reductarians/flexitarians (intentionally reducing intake of animal-based products)
  2. History of a disease known to affect intermediary metabolism (e.g., any diabetes on treatment, i.e. medication or lifestyle recommendations, thyreopathies, cancer etc.)
  3. BMI>30 kg/m2
  4. History of disease of intestinal integrity (i.e., inflammatory bowel disease, chronic pancreatitis, other malabsorption, etc.).
  5. Pregnant or breastfeeding females.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validity of the vegan screenerBaseline

The validity will be assessed by calculating associations between the screener and reference method.

Secondary Outcome Measures
NameTimeMethod
Dietary intakeBaseline

Dietary intake will be assessed using a weighed food record

Food habitsBaseline

Food habits will be assessed using a food frequency questionnaire

Vitamin D statusBaseline

Vitamin D status will be measured from venous blood samples

Homocysteine statusBaseline

Homocysteine will be measured from venous blood samples

Ferritin concentrationBaseline

Ferritin concentration will be determined from venous blood samples

Soluble transferrin receptor concentrationBaseline

Soluble transferrin receptor will be determined from venous blood samples

holo-transcobalaminBaseline

holo-transcobalamin will be measured from venous blood samples

Methylmalonic acidBaseline

Methylmalonic acid will be measured from venous blood samples

Folic acid statusBaseline

Folic acid will be measured from venous blood samples

Vitamin B2 statusBaseline

Vitamin B2 will be measured from venous blood samples

Zinc statusBaseline

Zinc status will be determined from venous blood samples

Selenoprotein-P statusBaseline

Selenoprotein-P status will be determined from venous blood samples

Creatinine concentrationBaseline

Creatinine will be determined from venous blood samples

Uric acid concentrationBaseline

Uric acid will be determined from venous blood samples

Urea concentrationBaseline

Urea will be determined from urine samples samples

Iodine concentrationBaseline

Iodine status will be determined from urine samples

Potassium concentrationBaseline

Potassium status will be determined from urine samples

Sodium concentrationBaseline

Sodium status will be determined from urine samples

Vitamin C statusBaseline

Vitamin C will be measured from venous blood samples

Magnesium statusBaseline

Magnesium status will be determined from venous blood samples

Hemoglobin concentrationBaseline

Hemoglobin will be determined from venous blood samples

Calcium concentrationBaseline

Calcium status will be determined from urine samples

Creatinine concentration (urine)Baseline

Creatinine will be determined from urine samples

C-reactive protein concentrationBaseline

The inflammatory marker hsCRP will be determined from serum

Triglyceride concentrationBaseline

Triglyceride concentration will be determine from venous blood samples

Free fatty acid concentrationBaseline

Free fatty acid concentration will be determine from venous blood samples

Eicosapentanoic acidBaseline

Eicosapentanoic acid (in % of total FA) will be determine from venous blood samples

Docosahexanoic acidBaseline

Docosahexanoic acid (in % of total FA) will be determine from venous blood samples

LDL-cholesterol concentrationBaseline

LDL-cholesterol concentration will be determine from venous blood samples

HDL-Cholesterol concentrationBaseline

HDL-Cholesterol concentration will be determine from venous blood samples

Cholesterol concentrationBaseline

Cholesterol concentration will be determine from venous blood samples

Glucose concentrationBaseline

Glucose will be measured from venous blood samples

Well beingBaseline

Participants well being will be assessed using a questionnaire. The scale of each question ranges from 0 to 10, 10 representing the highest well being

VEGANScreenerBaseline and day 2

The VEGANScreener assesses diet quality using 29 questions of frequency of consumption of different foods and food groups.

WeightBaseline

Weight will be measured in kg

HeightBaseline

Height will be measured in m

Waist circumferenceBaseline

Waist circumference will be measured in cm

Hip circumferenceBaseline

Hip circumference will be measured in cm

Trial Locations

Locations (1)

UZ Gent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath